Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer
Clinical trial NCT03602586 · COMPLETED
Trial details
- NCT number
- NCT03602586
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-21
- Primary completion
- 2021-02-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.